Is Yatsen setting its sights on famous but struggling Erno Laszlo?
Recent signals hint the Chinese skincare and cosmetics maker could be eying a purchase of the U.S. brand, whose sale to a Chinese investment group was disclosed this week Key…
BRIEF: Yatsen pares losses on booming skincare business
Cosmetics retailer Yatsen Holding Ltd. (YSG.US) announced on Monday that its revenue rose 26.7% last year to 4.3 billion yuan ($614.6 million), up from 3.39 billion yuan in 2024. Its…
Good product? Perhaps, but HBN’s real glow comes from guerilla marketing
The skincare brand has filed to list in Hong Kong, reporting meteoric profit growth in the six years since its launch in 2019 Key Takeaways: HBN has applied for a…
BRIEF: Forest Cabin rises in Hong Kong debut
Shares of skincare products maker Shanghai Forest Cabin Cosmetics Group Co. Ltd. (2657.HK) opened up 9.3% at HK$85 in their Hong Kong trading debut on Tuesday, then continued to rise to close up…
Forest Cabin outpowers L’Occitane, global rivals with aggressive marketing
The 22-year-old skincare brand has filed for a Hong Kong IPO, boasting a higher gross margin than its larger European peer Key Takeaways: Forest Cabin has filed for a Hong…
Labubu fever, and a skincare brawl
An early edition toy based on the red-hot Labubu character has fetched a record $150,000 in a recent auction. What's driving the craze, and is it sustainable? And a high-profile tussle between two leading skincare brands has left one of them bruised, with its stock down 30%. How can investors steer clear of this kind of damage?
Biogene gets bruised in ‘Battle of the skincare belles’
A squabble involving false advertising claims by a sinking Bloomage Biotech against highflying rival Giant Biogene has captivated China, with no end in sight Key Takeaways: Shares of Giant Biogene…